Structural biology institute increases talent

BUFFALO, New York, August 1, 2017- Hauptman-Woodward Medical Research Institute (HWI), an international leader in structural biology research, announced today an addition to its scientific team with the hiring of Associate Research Scientist, Sarah Bowman, PhD. Bowman will head the Institute’s High Throughput Crystallization Screening Center, a well-regarded center in the field that has helped over 1,000 other research groups globally study the most diverse and largest group of potential pharmaceutical targets worldwide.

Dr. Bowman comments, “I found the opportunity to join the team at HWI an impossible one to pass up. The Institute is committed to advancing the science and art of structural biology and recognizes its essential role in bridging the gap between research and education. HWI has been known not only for its research, but for also developing cutting-edge methods that further the field. I am thrilled to be part of this talented and accomplished organization.”

“Sarah has a proven ability to conduct and lead innovative research and simultaneously focus on making STEM disciplines exciting for the next generation. She has been a champion for increasing the numbers of women, under-represented students, and first-generation college students in the sciences. Her breadth of experience pushes our mission at HWI to innovate, discover, and educate. I am tremendously excited that we can attract such talent to Buffalo,” said Edward Snell, PhD, CEO of Hauptman-Woodward.

Prior to joining Hauptman-Woodward, Dr. Bowman held positions at Los Alamos National Laboratory and Massachusetts Institute of Technology. She graduated with a PhD in Chemistry from the University of Rochester, and also holds undergraduate degrees from Cornell College in IA and Metropolitan State College of Denver.

About Hauptman-Woodward Medical Research Institute

Hauptman-Woodward Medical Research Institute’s work improves human health by studying the causes of diseases, as well as potential therapies, at their basic molecular level. HWI is a founding member of the Buffalo Niagara Medical Campus, and resides in a state-of-the-art research facility at 700 Ellicott Street. For more information, visit The HWI High Throughput Crystallization Screening Center can be found at